Skip to main content
Clinical Trials/ISRCTN06023644
ISRCTN06023644
Completed
Phase 4

An investigation into the genes underlying the clinical syndrome of aspirin resistance: a non-randomised interventional treatment trial

Kings College London (UK)0 sites100 target enrollmentApril 23, 2010

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Topic: Cardiovascular
Sponsor
Kings College London (UK)
Enrollment
100
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 23, 2010
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional

Investigators

Sponsor
Kings College London (UK)

Eligibility Criteria

Inclusion Criteria

  • Male or female aged 18 or more

Exclusion Criteria

  • 1\. Significant co\-morbidity
  • 2\. Current regular therapy with any drug
  • 3\. Ingestion of aspirin, other non\-steroidal anti\-inflammatory drug, or other anti\-platelet agent within the previous 30 days
  • 4\. Previous reaction to aspirin or other anti\-platelet drug
  • 5\. History of dyspepsia or peptic ulceration
  • 6\. Pregnancy or female currently trying to conceive. Females of reproductive age wishing to take part will be asked to undergo a pregnancy test prior to inclusion, and will participate only if the test is negative.

Outcomes

Primary Outcomes

Not specified

Similar Trials